Bradlow HL - Search Results

1

Estrogen hydroxylation--the good and the bad.

Sepkovic DW, Bradlow HL. Sepkovic DW, et al. Among authors: bradlow hl. Ann N Y Acad Sci. 2009 Feb;1155:57-67. doi: 10.1111/j.1749-6632.2008.03675.x. Ann N Y Acad Sci. 2009. PMID: 19250192 Review.

2

Diet and breast cancer.

Bradlow HL, Sepkovic DW. Bradlow HL, et al. Ann N Y Acad Sci. 2002 Jun;963:247-67. doi: 10.1111/j.1749-6632.2002.tb04117.x. Ann N Y Acad Sci. 2002. PMID: 12095951

3

Steroids as procarcinogenic agents.

Bradlow HL, Sepkovic DW. Bradlow HL, et al. Ann N Y Acad Sci. 2004 Dec;1028:216-32. doi: 10.1196/annals.1322.027. Ann N Y Acad Sci. 2004. PMID: 15650248 Review.

4

Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Sepkovic DW, Stein J, Carlisle AD, Ksieski HB, Auborn K, Bradlow HL. Sepkovic DW, et al. Among authors: bradlow hl. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2957-64. doi: 10.1158/1055-9965.EPI-09-0698. Epub 2009 Oct 27. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19861518 Free PMC article.

5

Urinary estrogen metabolites and their ratio among Asian American women.

Falk RT, Fears TR, Xu X, Hoover RN, Pike MC, Wu AH, Nomura AM, Kolonel LN, West DW, Sepkovic DW, Bradlow HL, Ziegler RG. Falk RT, et al. Among authors: bradlow hl. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):221-6. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668498

6

Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites.

Bradlow HL, Jernström H, Sepkovic DW, Klug TL, Narod SA. Bradlow HL, et al. Mol Genet Metab. 2006 Feb;87(2):135-46. doi: 10.1016/j.ymgme.2005.08.001. Epub 2005 Sep 13. Mol Genet Metab. 2006. PMID: 16165383

7

Estrogen metabolism and breast cancer.

Kabat GC, O'Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Bradlow HL. Kabat GC, et al. Among authors: bradlow hl. Epidemiology. 2006 Jan;17(1):80-8. doi: 10.1097/01.ede.0000190543.40801.75. Epidemiology. 2006. PMID: 16357599

8

Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.

Greenlee H, Chen Y, Kabat GC, Wang Q, Kibriya MG, Gurvich I, Sepkovic DW, Bradlow HL, Senie RT, Santella RM, Ahsan H. Greenlee H, et al. Among authors: bradlow hl. Breast Cancer Res Treat. 2007 Mar;102(1):111-7. doi: 10.1007/s10549-006-9308-7. Epub 2006 Jul 19. Breast Cancer Res Treat. 2007. PMID: 16850246

9

3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK. Rajoria S, et al. Among authors: bradlow hl. Thyroid. 2011 Mar;21(3):299-304. doi: 10.1089/thy.2010.0245. Epub 2011 Jan 22. Thyroid. 2011. PMID: 21254914 Free PMC article. Clinical Trial.

10

Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.

Sepkovic DW, Stein J, Carlisle AD, Ksieski HB, Auborn K, Raucci L, Nyirenda T, Bradlow HL. Sepkovic DW, et al. Among authors: bradlow hl. Cancer Prev Res (Phila). 2011 Jun;4(6):890-6. doi: 10.1158/1940-6207.CAPR-10-0369. Epub 2011 Mar 7. Cancer Prev Res (Phila). 2011. PMID: 21383027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page